Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Flow Cytometry Detects Myelodysplasia in Peripheral Blood

By LabMedica International staff writers
Posted on 27 Mar 2018
Myelodysplastic Syndromes (MDS) are a group of myeloid neoplasms characterized by inefficient hematopoiesis, peripheral blood (PB) cytopenias and high risk of leukemic progression.

The diagnosis of MDS is essentially based on morphological and cytogenetic abnormalities, such as the presence of cytopenias, blasts in the PB and/or bone marrow (BM), and dysplasia in one or more hematopoietic cell lineages. More...
Although PB cytomorphological findings provide information to suspect of MDS, only BM studies are presently accepted to confirm the diagnosis.

Scientists associated with the Hospital de Santo António Porto (Porto, Portugal) studied 14 patients with low-risk MDS (LR-MDS), eight males and six females, with a median age of 76 years, ranging from 66 to 88 years and that had at least one appointment at the hospital from September 2015 to November 2015. An equal number of healthy blood donor controls were studied in parallel, eight males and six females, with a median age of 55 years, ranging 19 to 63 years.

Clinical and laboratory data were retrospectively collected from the hospital records. Bone marrow (BM) aspirate samples were used to prepare BM smears. These were stained with Leishman’s stain, and cell morphology was analyzed by conventional light microscopy. Cytogenetics studies were performed on BM aspirates, either by conventional cytogenetics and/or fluorescence in situ hybridization (FISH).

Peripheral blood samples were collected into ethylene-diamine-tetra-acetic acid tripotassium salt containing tubes and processed within 24 hours after collection. Cell immunophenotyping was performed by 8-color flow cytometry (FCM) using fluorochrome-conjugated monoclonal antibodies (mAbs) with different specificities. Sample acquisition was performed in a BD FACSCanto II flow cytometer.

The team found that peripheral blood neutrophils from patients with LR-MDS frequently had low forward scatter (FSC) and side scatter (SSC) values and low levels of CD11b, CD11c, CD10, CD16, CD13 and CD45 expression, in that order, as compared to normal neutrophils. In addition, patients with LR-MDS commonly display a higher fraction of CD14+CD56+ and a lower fraction of CD14+CD16+ monocytes in the PB. The immunophenotyping score based on which PB samples from patients with LR-MDS could be distinguished from normal PB samples with a sensitivity of 93% and a specificity of 100%.

The authors concluded that their pilot study revealed an altered neutrophil immunophenotype, often accompanied by an abnormal monocyte immunophenotype, in the PB from nearly all LR-MDS cases, and suggest that assessment of abnormal antigen expression in PB mature myeloid cells may help to identify patients with LR-MDS. Once translated into a straightforward FCM-based score and converted into a visual analogue scale, MDS thermometer, these findings can be easily applied in clinical practice. The study was published on March 13, 2018, in the journal BMC Hematology.

Related Links:
Hospital de Santo António Porto


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.